The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in ...

Approval of Opdivo plus Yervoy combination was based on results from the Phase III CheckMate-9DW trial, which demonstrated ...

Jessica Zbinden-Webster was diagnosed with a rare kind of basal cell carcinoma when she was just 26, now she campaigns to ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

A phase 1 clinical trial is now open for enrollment to patients with high-grade neuroendocrine tumors to receive treatment with a combination of immunotherapy and what has been described in a news ...

Donald Trump has suffered a skin cancer scare following his latest medical report after doctors found "benign lesions" ...

AU-007, combined with Opdivo and low-dose aldesleukin, has entered a phase 2 melanoma trial, with early data showing activity ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of patients diagnosed at ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

Soha Ali Khan reveals Sharmila Tagore’s early-stage lung cancer battle Learn how early detection saved her life and the ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...